Zusammenfassung
Der Verlauf der Schizophrenie ist unterschiedlich. Eine besondere Gruppe chronischer Fälle — die derzeitige Population entspricht in etwa der Gruppe, die vor Einführung der Neuroleptika Anfang der fünfziger Jahre in den psychiatrischen Krankenhäusern war — zeigt verschiedene Formen einer mehr oder weniger schweren Behinderung in medizinischer wie sozialer Hinsicht. Ziel dieses Symposiums über eine Standortbestimmung (»reconnaissance workshop«) ist es, Behandlungsstrategien für diese Gruppe von schwerkranken Patienten zu diskutieren.
Wir sind davon überzeugt, daß viel mehr für diese chronisch schizophrenen Patienten getan werden könnte, wenn bestimmte therapeutische Prinzipien akzeptiert und in der Praxis angewandt würden. Der folgende Beitrag bringt eine kurze Hintergrundbeschreibung des Problems mit Patientencharakteristika, den verschiedenen Einstellungen zu diesem Problem, den wichtigsten Gesichtspunkten der Weiterbehandlung und den zu verwendenden Beziehungsgrößen, um Wirksamkeit und Qualität der Behandlung beurteilen zu können.
Aus dem Englischen übertragen von Dr. F. Kulhanek, München
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
Alanen YO, Rakkolainen V, Rasimus R., Developing the treatment of schizophrenia in a community-psychiatric setting: A psychotherapeutic and family-centered approach. Psychiatr Fenn 1982; 101–120.
Asberg M, Perris C, Schalling D, Sedvall G., The Cprs — Developments and applications of a psychiatric rating scale. Acta Psychiatr Scand 1978; Suppl 271.
Beard JH, Malamud TJ, Rossman E., Psychiatric rehabilitation and long-term rehospi- talization rates: the findings of two research studies. Schizophr Bull 1978; 4: 622–635.
Cowden RC, Zax M, Sproles JA., Reserpine: alone and as an adjunct to psychotherapy in the treatment of schizophrenia. Am Med Ass Arch Neurol Psychiatry 1955; 74: 518–522.
Cowden RC, Zax M, Hague JR., Chlorpromazine. Alone and as an adjunct to group psycho-therapy in the treatment of psychiatric patients. Am J Psychiatry 1956; 113: 898–902.
Dencker SJ., Hospital-based community support services for recovering chronic schizophrenics. New York: World Rehabilitation Fund, 1980.
Dencker SJ, Frankenberg K, Hansen V., Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the Cprs subscale for schizophrenia. Acta Psychiatr Scand 1980; Suppl 279: 29–41.
Dencker SJ, Malm U., Combination of neuroleptics and psychosocial therapies in schizophrenia. Nord Psychiatr Tidsskr 1984; 38: 27–30.
Dencker SJ, Malm U, Lepp M., Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatr Scand 1986 (im Druck).
Freeman H., Organization of continuous care in schizophrenia. In: What does the schizophrenic outpatient need? Proceedings from a workshop in Copenhagen, February 8–9, 1979: 25–29.
Grinspoon L, EwAlt JR, Shader RI., Schizophrenia, pharmacotherapy and psychotherapy. Baltimore: Williams and Wilkins, 1972.
Hirsch SR, Gaind R, Rohde PD, Stevens BC, Wing JK., Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine, A double-blind placebo trial. Br Med J 1973; 1: 633–637.
Hogarty GE, Ulrich RF, Mussare F., Drug discontinuation among long term successfully maintained schizophrenic outpatients. Dis Nerv Syst 1976; 37: 494–500.
Hogarty GE, Schooler NR, Ulrich R., Fluphenazine and social therapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 1979; 36: 1283–1294.
Honigfeld G, Rosenblum MP, Blumenthal IJ., Behavioral improvement in the older schizophrenic patient: drug and social therapies. J Am Geriatr Soc 1964; 13: 57–72.
Johnson Daw., The expectation of outcome from maintenance therapy in chronic schizophrenic patients. Br J Psychiatry 1976; 128: 246–250.
Lindberg D., Management of schizophrenia. Long-term clinical studies with special reference to the combination of psychotherapy with depot neuroleptics. Acta Psychiatr Scand 1981; 63 (Suppl 289).
Malm U, May Pra, Dencker SJ., Evaluation of the quality of life of the schizophrenic outpatient: A checklist. Schizophr Bull 1981; 7: 477–487.
Malm U., The influence of group therapy on schizophrenia. Acta Psychiatr Scand 1982; 65 (Suppl 297).
May Pra., Treatment of schizophrenia: A comparative study of five treatment methods. New York: Science House, 1968.
May Pra., Rational treatment for an irrational disorder: What does the schizophrenic patient need? Am J Psychiatry 1976; 133: 1008–1012.
Miles CP., Conditions predisposing to suicide: A review. J Nerv Ment Dis 1977; 164: 23 1246.
Roy A, Mazonson A, Pickar D., Attempted suicide in chronic schizophrenia. Br J Psychiatry 1984; 144: 303–306.
SJösTRÖM R., Effects of psychotherapy in schizophrenia. A retrospective study. Acta Psychiatr Scand 1985; 71: 513–522.
Ugelstad E., Psychosocial treatment alternatives for long-stay schizophrenic patients. In: Jorstad J, Ugelstad E, eds. Schizophrenia 75. Oslo: Universitetsforlaget, 1976: 397–412.
Weisbrod BA, Test MA, Stein LI., An alternative to mental hospital treatment: Iii. Economic benefit cost analysis. University of Wisconsin, 1978.
Wing JK, Brown GW., Institutionalism and schizophrenia. A comparative study of three mental hospitals 1960–68. Cambridge: Cambridge University Press, 1979.
Wistedt B., A depot neuroleptic withdrawal study. Acta Psychiatr Scand 1981; 64: 65–84.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Dencker, S.J., May, P.R.A. (1988). Von der Langzeitbehandlung im psychiatrischen Krankenhaus zur Integration in die Gesellschaft: Historischer Hintergrund und Problemstellung. In: Bender, W., Dencker, S.J., Kulhanek, F. (eds) Schizophrene Erkrankungen. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01928-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-663-01928-2_10
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-663-01929-9
Online ISBN: 978-3-663-01928-2
eBook Packages: Springer Book Archive